Our Latest Stories

Your Health
March 7, 2025
MMoving Forward: Sparking Change in Multiple Myeloma

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
83
Compounds in clinical development
26
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
March 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
March 5, 2025
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
February 28, 2025
Media Update: AAD: new data advance Sanofi’s scientific leadership across innovative treatments for inflammatory skin diseases
February 25, 2025
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma